When will there finally be an effective drug against Alzheimer's? Why is it still almost impossible to cure neurodegnerative diseases? And how can the latest reports of therapeutic successes in slowing down dementia be scientifically classified? Our host Thomas Ramge talks to Prof. Dr. Markus Zweckstetter, particle physicist, biochemist and founder of the biotech start-up brain qr therapeutics. Listen to the episode (in German).